Furthermore, the number of infiltrated CD3+, CD4+, and CD8+ T cells was also significantly elevated in the TME with ME49Δgra5 injection compared with PBS injection, but no significant difference was found with these infiltrated cells in the TME of the distant 4T1 tumor and the PBS-injected tumor. The gene discussed is CD8A; the disease is neoplasm.